NE BUSINESS BUREAU
MUMBAI, NOV 5
Procter & Gamble Health Ltd. for the second quarter ended September 30 reported 26% growth in net profit to ₹82 crore from the year-earlier period. In the corresponding quarter of the previous fiscal, it posted a net profit of ₹65.6 crore. The company during the quarter reported sales of ₹310 crore, up 3% over the year ago period. Operational PAT is up 8% vs. year ago, excluding one-time impact in the base period.
Revenue from operations increased 2.8% to ₹313.4 crore against ₹304.9 crore in the year-ago period. At the operating level, EBITDA climbed 28.7% to ₹114.1 crore in the second quarter of this fiscal over ₹88.7 crore Q2 of FY24.
Commenting on the results, Milind Thatte, Managing Director, P&G Health India in a statement said, “Our first- quarter results represent a sequential improvement. Our strategy, centered on a focused portfolio of quality, trusted, and highly recommended brands where performance drives brand choice; superiority (across product, package, brand communication, retail execution, and value), constructive disruption and an agile accountable organization”.
He further added, “We are dedicated to enhancing consumer awareness programs and strengthening our relationships with our customers and stakeholders. We continue to invest in initiatives that address the evolving needs of both consumers and healthcare professionals, along with strengthening our go-to-market model. We have also strengthened our reach, distribution, and retail execution, positioning us for long-term competitiveness”.
